Alnylam Pharmaceuticals
ALNY
#508
Rank
$47.43 B
Marketcap
$359.03
Share price
-0.08%
Change (1 day)
43.03%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company